US FDA Authority over Imports
This article was originally published in SRA
In recent years, the US Food and Drug Administration has faced increasing challenges in overseeing the safety of agency-regulated products generally, and particularly imported pharmaceutical products from developing countries. The agency carries out several hundred inspections each year of foreign pharmaceutical establishments that ship products to the US. The number inspected each year, however, is only a small fraction of the total.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.